Recently, our study showed that cells with activated Wnt signaling and EMT program showed higher RUNX2 expression in a heterogeneous colorectal cancer cell population and that overexpression of RUNX2 enhanced cell migration in colon cancer cells, as well as in many other cancer cells, including bladder, glioma, cervical, liver, and lung cancers [19]. The gene discussed is RUNX2; the disease is glioma.